Investigational Site Number 840018 — New York, New York

Investigational Site Number 840018 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840018 has participated in 2 clinical trials.

Therapeutic areas: Hematopoietic Neoplasm, Type 2 Diabetes Mellitus.

Sponsors: Bristol-Myers Squibb, Sanofi.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840018?

Investigational Site Number 840018 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840018 conducted?

Investigational Site Number 840018 has 2 clinical trials on record. Their work covers Hematopoietic Neoplasm, Type 2 Diabetes Mellitus.

Is Investigational Site Number 840018 accredited by Crixeo Health?

Investigational Site Number 840018 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840018?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.